171 related articles for article (PubMed ID: 38750492)
1. The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
Cadham CJ; Oh H; Han MK; Mannino D; Cook S; Meza R; Levy DT; Sánchez-Romero LM
Respir Res; 2024 May; 25(1):208. PubMed ID: 38750492
[TBL] [Abstract][Full Text] [Related]
2. Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
Wan ES; Balte P; Schwartz JE; Bhatt SP; Cassano PA; Couper D; Daviglus ML; Dransfield MT; Gharib SA; Jacobs DR; Kalhan R; London SJ; Navas-Acien A; O'Connor GT; Sanders JL; Smith BM; White W; Yende S; Oelsner EC
JAMA; 2021 Dec; 326(22):2287-2298. PubMed ID: 34905031
[TBL] [Abstract][Full Text] [Related]
3. Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010.
Tilert T; Dillon C; Paulose-Ram R; Hnizdo E; Doney B
Respir Res; 2013 Oct; 14(1):103. PubMed ID: 24107140
[TBL] [Abstract][Full Text] [Related]
4. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study.
Wijnant SRA; De Roos E; Kavousi M; Stricker BH; Terzikhan N; Lahousse L; Brusselle GG
Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31601717
[TBL] [Abstract][Full Text] [Related]
5. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
Higbee DH; Granell R; Davey Smith G; Dodd JW
Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
[TBL] [Abstract][Full Text] [Related]
7. Trajectories of Spirometric Patterns, Obstructive and PRISm, in a Population-Based Cohort in Latin America.
Perez-Padilla R; Montes de Oca M; Thirion-Romero I; Wehrmeister FC; Lopez MV; Valdivia G; Jardim JR; Muino A; B Menezes AM;
Int J Chron Obstruct Pulmon Dis; 2023; 18():1277-1285. PubMed ID: 37366430
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and Characteristics of Individuals with Preserved Ratio Impaired Spirometry (PRISm) and/or Impaired Lung Function in Japan: The OCEAN Study.
Kaise T; Sakihara E; Tamaki K; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R
Int J Chron Obstruct Pulmon Dis; 2021; 16():2665-2675. PubMed ID: 34588775
[TBL] [Abstract][Full Text] [Related]
9. Significant predictors of medically diagnosed chronic obstructive pulmonary disease in patients with preserved ratio impaired spirometry: a 3-year cohort study.
Park HJ; Byun MK; Rhee CK; Kim K; Kim HJ; Yoo KH
Respir Res; 2018 Sep; 19(1):185. PubMed ID: 30249256
[TBL] [Abstract][Full Text] [Related]
10. Association between Comorbidities and Preserved Ratio Impaired Spirometry: Using the Korean National Health and Nutrition Examination Survey IV-VI.
Kim J; Lee CH; Lee HY; Kim H
Respiration; 2022; 101(1):25-33. PubMed ID: 34320510
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry: An Observational Cohort Study.
Ogata H; Sha K; Kotetsu Y; Enokizu-Ogawa A; Katahira K; Ishimatsu A; Taguchi K; Moriwaki A; Yoshida M
Int J Chron Obstruct Pulmon Dis; 2022; 17():2791-2799. PubMed ID: 36339246
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.
Wan ES; Fortis S; Regan EA; Hokanson J; Han MK; Casaburi R; Make BJ; Crapo JD; DeMeo DL; Silverman EK;
Am J Respir Crit Care Med; 2018 Dec; 198(11):1397-1405. PubMed ID: 29874098
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics and Medical Utilization of Smokers with Preserved Ratio Impaired Spirometry.
Shin YY; Park S; Kim KJ; Rhee CK; Yoo KH; Jung KS; Lee JH
Int J Chron Obstruct Pulmon Dis; 2023; 18():2187-2194. PubMed ID: 37822330
[TBL] [Abstract][Full Text] [Related]
14. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
[TBL] [Abstract][Full Text] [Related]
15. Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort Study.
Krishnan S; Tan WC; Farias R; Aaron SD; Benedetti A; Chapman KR; Hernandez P; Maltais F; Marciniuk DD; O'Donnell DE; Sin DD; Walker B; Bourbeau J;
Chest; 2023 Sep; 164(3):637-649. PubMed ID: 36871842
[TBL] [Abstract][Full Text] [Related]
16. Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.
Martinez CH; Mannino DM; Jaimes FA; Curtis JL; Han MK; Hansel NN; Diaz AA
Ann Am Thorac Soc; 2015 Dec; 12(12):1788-95. PubMed ID: 26524488
[TBL] [Abstract][Full Text] [Related]
17. Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).
Wei X; Ding Q; Yu N; Mi J; Ren J; Li J; Xu S; Gao Y; Guo Y
Lung; 2018 Dec; 196(6):649-658. PubMed ID: 30218155
[TBL] [Abstract][Full Text] [Related]
18. Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations.
Regan EA; Lowe ME; Make BJ; Curtis JL; Chen QG; Crooks JL; Wilson C; Oates GR; Gregg RW; Baldomero AK; Bhatt SP; Diaz AA; Benos PV; O'Brien JK; Young KA; Kinney GL; Conrad DJ; Lowe KE; DeMeo DL; Non A; Cho MH; Kallet J; Foreman MG; Westney GE; Hoth K; MacIntyre NR; Hanania NA; Wolfe A; Amaza H; Han M; Beaty TH; Hansel NN; McCormack MC; Balasubramanian A; Crapo JD; Silverman EK; Casaburi R; Wise RA
Am J Respir Crit Care Med; 2024 Jan; 209(1):59-69. PubMed ID: 37611073
[No Abstract] [Full Text] [Related]
19. Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
Lu J; Ge H; Qi L; Zhang S; Yang Y; Huang X; Li M
Respir Res; 2022 Nov; 23(1):309. PubMed ID: 36369019
[TBL] [Abstract][Full Text] [Related]
20. Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment.
Labaki WW; Gu T; Murray S; Curtis JL; Wells JM; Bhatt SP; Bon J; Diaz AA; Hersh CP; Wan ES; Kim V; Beaty TH; Hokanson JE; Bowler RP; Arenberg DA; Kazerooni EA; Martinez FJ; Silverman EK; Crapo JD; Make BJ; Regan EA; Han MK; ;
Am J Respir Crit Care Med; 2023 Aug; 208(4):451-460. PubMed ID: 37159910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
